Fertility and Sterility
Volume 89, Issue 2 , Pages 342-347 , February 2008

Gonadotropin-releasing hormone agonist/antagonist conversion with estrogen priming in low responders with prior in vitro fertilization failure

  • Jeffrey D. Fisch, M.D.

      Affiliations

    • Sher Institute for Reproductive Medicine, Las Vegas, Nevada
    • Corresponding Author InformationReprint requests: Jeffrey D. Fisch, M.D., Sher Institute for Reproductive Medicine, Las Vegas, 3121 S. Maryland Parkway, Suite 300, Las Vegas, NV 89109 (FAX: 702-892-9666).
    • ,
  • Levent Keskintepe, Ph.D.

      Affiliations

    • Sher Institute for Reproductive Medicine, Las Vegas, Nevada
    • ,
  • Geoffrey Sher, M.D.

      Affiliations

    • Sher Institute for Reproductive Medicine, Las Vegas, Nevada
    • Department of Obstetrics and Gynecology, University of Nevada School of Medicine, Reno, Nevada

Received 6 June 2006 ,Revised 2 March 2007 ,Accepted 2 March 2007.

References 

  1. Speroff L, Fritz M. Molecular biology for clinicians; Regulation of the menstrual cycle; Assisted reproductive technologies. In:  Speroff L,  Fritz MA editor. Clinical gynecologic endocrinology and infertility. 7th ed.. Philadelphia, PA: Lippincott Williams and Wilkins; 2005;
  2. Battaglia DE, Goodwin P, Klein NA, Soules MR. Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women. Hum Reprod. 1996;11:2217–2222
  3. Angell R. First meiotic-division nondisjunction in human oocytes. Hum Genet. 1997;61:23–32
  4. Pellestor F, Andreo B, Arnal F, Humeau C, Demaille J. Maternal aging and chromosomal abnormalities: new data drawn from in vitro unfertilized human oocytes. Hum Genet. 2003;112:195–203
  5. Gianaroli L, Magli MC, Ferraretti AP, Fiorentino A, Garrisi J, Munne S. Preimplantation genetic diagnosis increases the implantation rate in human in vitro fertilization by avoiding the transfer of chromosomally abnormal embryos. Fertil Steril. 1997;68:1128–1131
  6. Magli MC, Jones GM, Gras L, Gianaroli L, Korman I, Trounson A. Chromosome mosaicism in day 3 aneuploid embryos that develop to morphologically normal blastocysts in vitro. Hum Reprod. 2000;15:1781–1786
  7. Padilla SL, Dugan K, Maruschak V, Shalika S, Smith RD. Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization. Fertil Steril. 1996;65:796–799
  8. Surrey ES, Bower J, Hill DM, Ramsey J, Surrey MW. Clinical and endocrine effects of a micro dose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril. 1998;69:419–424
  9. Diedrich K, Diedrich C, Santos E, Zoll C, al-Hasani S, Reissman T, et al. Suppression of the endogenous luteinizing hormone surge by the gonadotropin releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod. 1994;9:788–791
  10. Borm G, Mannaerts B. Treatment with the gonadotropin releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle-stimulating hormone is effective, safe and convenient: results of a controlled, randomized multicentre trial. The European Orgalutran Study Group. Hum Reprod. 2000;15:1490–1498
  11. Fluker M, Grifo J, Leader A, Levy M, Meldrum D, Mushauer SJ, et al. Efficay and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril. 2001;75:38–45
  12. Elkind-Hirsch KE, Webster BW, Brown CP, Vernon MW. Concurrent ganirelix and follitropin B-therapy is an effective and safe regimen for ovulation induction in women with polycystic ovarian syndrome. Fertil Steril. 2003;79:603–607
  13. Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Initiation of gonadotropin releasing hormone antagonist on day 1 as compared to day 6 of the stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles. J Clin Endocrinol Metab. 2003;88:5632–5637
  14. Kolibianakis EM, Albano C, Kahn J, Camus M, Tournaye H, Van Steirteghem AC, et al. Exposure to high levels luteinizing hormone and estradiol in the early follicular phase of gonadotropin releasing hormone antagonist cycles is associated with a reduced chance of pregnancy. Fertil Steril. 2003;79:873–880
  15. Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Relationship between LH and oestradiol in IVF cycles before GnRH antagonist initiation. Reprod Biomed Online. 2003;7:190–193
  16. Fisch JD, Sher G, Keskintepe L. A randomized, controlled trial of low dose GnRH antagonist started on day 2 in poor responders undergoing stimulation with luteal phase GnRH agonist, estrogen priming and high-dose FSH. Oral presentation at the 59th Annual meeting of the American Society for Reproductive Medicine, San Antonio, Texas, October 11–15, 2003.
  17. Fisch JD, Sher G, Rodriguez H, Overby G, Adamowicz M, Keskintepe L. Graduated embryo score (GES) is superior to day-3 morphologic criteria alone for predicting ART outcome. Fertil Steril. 2003;80:1352–1358
  18. Keskintepe L, Fisch JD, Adamowicz M, Zody R, Sher G. Transferring embryos to blastocyst medium 46 hrs post ICSI in preparation for day 3 embryo transfer, improves implantation and pregnancy potential. Poster presentation at the 59th annual meeting of the American Society for Reproductive Medicine; San Antonio, Texas; October 11–15, 2003.
  19. Practice Committee of the Society for Assisted Reproductive TechnologyAmerican Society for Reproductive Medicine. Guidelines for the number of embryos transferred. Fertil Steril. 2004;84(Suppl 1):S1–S2
  20. McNatty KP, Makris A, DeGrazia C, Osathanondh R, Ryan KJ. The production of progesterone, androgens and estrogens by granulosa cells, thecal tissue and stromal tissue from human ovaries in vitro. J Clin Endocrinol Metab. 1979;49:687–699
  21. McNatty KP, Makris A, DeGraziak C, Osathanondh R, Ryan KJ. Steroidogenesis by recombined follicular cells from human ovary in vitro. J Clin Endorinol Metab. 1980;51:1286–1292
  22. Greisen S, Ledet T, Ovesen P. Effects of androstenedione, insulin and luteinizing hormone on steroidogenesis in human granulosa luteal cells. Hum Reprod. 2001;16:2061–2065
  23. Zelinski-Wooten MB, Hutchinson JS, Hess DL, Wolf DP, Stouffer RL. Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotropin-releasing hormone antagonist-treated monkeys. Hum Reprod. 1995;10:1658–1666
  24. Erickson GF, Magoffin DA, Dyer CA, Hofeditz C. The ovarian androgen producing cell: a review of structure/function relationships. Endocr Rev. 1985;6:371–399
  25. Chabab A, Hedon B, Arnal F, Diafouka F, Bressot N, Flandre O, et al. Follicular steroids in relation to oocyte development in human ovarian stimulation protocols. Hum Reprod. 1986;1:449–454
  26. The European Recombinant Human LH Study Group. Recombinant human luteinizing hormone (LH) to support recombinant human follicle stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose finding study. J Clin Endocrinol Metab. 1998;83:1507
  27. Kowalik A, Barmat L, Damariao M, Lui HC, Davis O, Rosenwaks Z. Ovarian estradiol production in vivo. Inhibitory effects of leuprolide acetate. J Reprod Med. 1998;43:413–417
  28. Schachter M, Friedler S, Raziel A, Strassburger D, Bern O, Ron-el R. Improvement of IVF outcome in poor responders by discontinuation of GnRH analogue during the gonadotropin stimulation phase—a function of improved embryo quality. J Assist Reprod Genet. 2001;18:197–204
  29. Land JA, Yarmolinskaya MI, Dumoulin JC, Evers JL. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril. 1996;65:961–965
  30. Fanchin R, Castelo-Branco A, Kadoch I, Hosny G, Bagirova M, Frydman R. Premenstrual administration of gonadotropin-releasing hormone antagonist coordinates early antral follicle sizes and sets up the basis for an innovative concept of controlled ovarian hyperstimulation concept. Fertil Steril. 2004;81:1554–1559
  31. Fanchin R, Schonauer LM, Cunha-Filho JS, Mendez-Lozano DH. Coordination of antral follicle growth: basis for innovative concepts of controlled ovarian hyperstimulation. Semin Reprod. 2005;23:354–362
  32. Tilly JL, Kowalski KI, Schomberg DW, Hsueh AJ. Apoptosis in atretic ovarian follicles is associated with selected decreases in messenger ribonucleic acid transcripts for gonadotropin receptors and cytochrome P450 aromatase. Endocrinology. 1992;131:1670–1676
  33. Hsueh AJW, Eisenhauer K, Chun SY, Hsu SY, Billing H. Gonadal cell apoptosis. Recent Prog Horm Res. 1996;51:433–455
  34. Andersen CY. Characteristics of human follicular fluid associated with successful conception after in vitro fertilization. J Clin Endocrinol Metab. 1993;77:1227–1234
  35. McNatty KP, Makris A, Reinhold VN, DeGrazia C, Osathanondh R, Ryan KJ. Metabolism of androstenedione by human ovarian tissues in vitro with particular reference to reductase and aromatase activity. Steroids. 1979;34:429–443
  36. Hiller SG, Van den Boogard AMJ, Reichert LE, Van Hall EV. Intraovarian sex steroid hormone interactions and the regulation of follicular maturation: aromatization of androgens by human granulosa cells in vitro. J Clin Endocrinol Metab. 1980;50:640–647
  37. Ackert CL, Gittens JE, O'Brien MJ, Eppig JJ, Kidder GM. Intracellular communication via connexin43 gap junctions is required for ovarian folliculogenesis in the mouse. Dev Biol. 2001;233:258–270
  38. Antagon (ganirelix acetate) injection package insert. West Orange, NJ: Organon USA; May 2004;
  39. Granot I, Dekel N. The ovarian gap junction protein connexin43: regulation by gonadotropins. Trends Endocrinol Metab. 2002;13:310–313
  40. McNatty KP, Smith DM, Makris A, DeGuzia C, Tulchinsky D, Osathanondh R, et al. The intraovarian sites of androgen and estrogen formation in women with normal and hyperandrogenic ovaries as judged by in vitro experiments. J Clin Endocrinol Metab. 1980;50:755–763
  41. Clark JR, Dierscke DJ, Wolf RC. Hormonal regulation of ovarian folliculogenesis in rhesus monkeys. III. Atresia of the preovulatory follicle induced by exogenous steroids and subsequent follicular development. Biol Reprod. 1981;25:332–341
  42. Fanchin R, Cunha-Filho JS, Schonauer LM, Kadoch IJ, Cohen-Bacri P, Frydman R. Coordination of early antral follicles by luteal estradiol administration provides a basis for alternative controlled ovarian hyperstimulation regimens. Fertil Steril. 2003;79:316–321

PII: S0015-0282(07)00535-3

doi: 10.1016/j.fertnstert.2007.03.004

Fertility and Sterility
Volume 89, Issue 2 , Pages 342-347 , February 2008

Article Tools